Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Marc Bourliere"'
Autor:
Jean-François David Cadranel, Isabelle Ollivier-Hourmand, Jacques Cadranel, Thierry Thevenot, Honoré Zougmore, Eric Nguyen-Khac, Christophe Bureau, Manon Allaire, Jean-Baptiste Nousbaum, Véronique Loustaud-Ratti, Xavier Causse, Philippe Sogni, Bertrand Hanslik, Marc Bourliere, Jean-Marie Peron, Nathalie Ganne-Carrie, Thong Dao, Dominique Thabut, Bernard. Maitre, Nabil Debzi, Ryad Smadhi, Roger Sombie, Raimi Kpossou, Olivier Nouel, Julien Bissonnette, Isaac Ruiz, Mourad Medmoun, Sergio Negrin Dastis, Pierre Deltenre, Florent Artru, Chantal Raherison, Laure Elkrief, Tristan Lemagoarou
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult. The aims of this article are which follows: To gather the practices of hepatogastroenterologi
Externí odkaz:
https://doaj.org/article/7ed104e147544c238702054de3ed2df3
Autor:
Georges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, Didier Samuel, Céline Dorival, Fabien Zoulim, Carole Cagnot, Thomas Decaens, Dominique Thabut, Tarik Asselah, Philippe Mathurin, François Habersetzer, Jean-Pierre Bronowicki, Dominique Guyader, Isabelle Rosa, Vincent Leroy, Olivier Chazouilleres, Victor de Ledinghen, Marc Bourliere, Xavier Causse, Paul Cales, Sophie Metivier, Véronique Loustaud-Ratti, Ghassan Riachi, Laurent Alric, Moana Gelu-Simeon, Anne Minello, Jérôme Gournay, Claire Geist, Albert Tran, Armand Abergel, Isabelle Portal, Louis d’Alteroche, François Raffi, Hélène Fontaine, Fabrice Carrat, Stanislas Pol, For the French ANRS CO22 Hepather Cohort
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a previous history of decompensated cirrhosis followi
Externí odkaz:
https://doaj.org/article/48e964b5c9d840cc88bf051e9f905689
Autor:
Anne Laurain, Sophie Metivier, Georges Haour, Dominique Larrey, Céline Dorival, Christophe Hezode, Fabien Zoulim, Patrick Marcellin, Marc Bourliere, Jean-Pierre Zarski, Dominique Thabut, Laurent Alric, Nathalie Ganne-Carrie, Paul Cales, Jean-Pierre Bronowicki, Ghassan Riachi, Claire Geist, Xavier Causse, Armand Abergel, Olivier Chazouilleres, Philippe Mathurin, Dominique Guyader, Didier Samuel, Albert Tran, Véronique Loustaud-Ratti, Ventzislava Petrov-Sanchez, Alpha Diallo, Clovis Luzivika-Nzinga, Hélène Fontaine, Fabrice Carrat, Stanislas Pol, on behalf of the ANRS/AFEF HEPATHER study group
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Although real-life results of sofosbuvir/simeprevir have been extensively reported from the United States, data from other geographical areas are limited. In the French observational cohort, ANRS CO22 HEPATHER, 9432 patients were
Externí odkaz:
https://doaj.org/article/7d26ddf8a567415e8bf3ac4e315b2fa7
Autor:
David E. Bernstein, Albert Tran, Paul Martin, Kris V. Kowdley, Marc Bourliere, Mark S. Sulkowski, Paul J. Pockros, Boris Renjifo, Deli Wang, Diana L. Shuster, Daniel E. Cohen, Ira M. Jacobson
Publikováno v:
Kidney International Reports, Vol 4, Iss 2, Pp 245-256 (2019)
Introduction: Patients with hepatitis C virus (HCV) infection and chronic kidney disease (CKD) are a high-priority population for treatment. Methods: We performed a post hoc pooled efficacy and safety analysis that included HCV genotype 1–infected
Externí odkaz:
https://doaj.org/article/fee2a1ab44074b91b2b9751f3f900276
Autor:
Philippe Halfon, Christelle Ansaldi, Guillaume Penaranda, Laurent Chiche, Patrick Dukan, Chloé Stavris, Anne Plauzolles, Frédérique Retornaz, Marc Bourliere
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254939 (2021)
Background & aimLiver fibrosis screening in primary care population is a major public health issue. The FIB-4 index is a simple non-invasive fibrosis test combining age, transaminases, platelets count, developed for the diagnosis of advanced fibrosis
Externí odkaz:
https://doaj.org/article/9e178689a7a34834a9928cdac8edf6e2
Autor:
Juliana Bruder Costa, Tania Dufeu-Duchesne, Vincent Leroy, Inga Bertucci, Magali Bouvier-Alias, Noelle Pouget, Ophelie Brevot-Lutton, Marc Bourliere, Fabien Zoulim, Joel Plumas, Caroline Aspord, ANRS HB06 PEGAN study group
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0158297 (2016)
Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune res
Externí odkaz:
https://doaj.org/article/af79ddd97184467bb9fcba0f5e0b0db9
Autor:
Caroline Aspord, Juliana Bruder Costa, Marie-Christine Jacob, Tania Dufeu-Duchesne, Inga Bertucci, Noelle Pouget, Ophelie Brevot-Lutton, Fabien Zoulim, Marc Bourliere, Joel Plumas, Vincent Leroy, ANRS HB06 PEGAN study group
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156200 (2016)
The ultimate goal of pegylated interferon-alfa-2a (Peg-IFN-α) therapy in chronic hepatitis B (CHB) infection is HBsAg seroconversion. Even though B cells are major mediators of a positive clinical outcome, their modulation during Peg-IFN-α therapy
Externí odkaz:
https://doaj.org/article/2c9f4f68ed5142e791cc06a6d45d60c5
Autor:
Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen
Publikováno v:
International Journal of Hepatology, Vol 2012 (2012)
High levels of profibrinogenic cytokine transforming factor beta (TGF-β), metalloprotease (MMP2), and tissue inhibitor of matrix metalloprotease 1 (TIMP1) contribute to fibrogenesis in hepatitis C virus (HCV) infection and in alcohol-induced liver d
Externí odkaz:
https://doaj.org/article/f7d89649ebb940a29853bcd21acf9e26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xavier, Adhoute, Marie, De Matharel, Laurent, Mineur, Guillaume, Pénaranda, Dann, Ouizeman, Clemence, Toullec, Albert, Tran, Paul, Castellani, Armelle, Rollet, Valérie, Oules, Hervé, Perrier, Si Nafa, Si Ahmed, Marc, Bourliere, Rodolphe, Anty
Publikováno v:
World Journal of Gastrointestinal Oncology. 14:1510-1527
Starting a second-line systemic treatment for hepatocellular carcinoma (HCC) is a common situation. The only therapeutic options in France are two broad-spectrum tyrosine kinase inhibitors (TKIs), regorafenib (REG) and cabozantinib (CBZ), but no comp